Exactly and if the primary end point had been a reduction in overall disease burden not some false dichotomy of inflammatory vs non inflammatory lesions we would not be having this conversation and the SP would be >30c. If the AD trial works out as per comments made by our Italian friend and we have 2 products in Ph3 plus the anti bacterial stuff to come we are talking about a SP>$1. But at this point we need to hold and not panic.
BOT: Moving Forward, page-89
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.0¢ |
Change
-0.015(3.90%) |
Mkt cap ! $672.4M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.5¢ | 36.5¢ | $2.603M | 7.036M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 292539 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 24998 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| BOT (ASX) Chart |